Company Filing History:
1 out of 20 
1 out of 2 Years Active: 2015
Title: Matthias Romauch: Innovator in Pharmaceutical Composition
Introduction
Matthias Romauch is a notable inventor based in Graz, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address serious health conditions. His work focuses on innovative solutions for disorders such as cachexia, stroke, atherosclerosis, coronary artery disease, and diabetes.
Latest Patents
Romauch holds a patent for ATGListatin and pharmaceutical compositions comprising the same. This compound is defined by a specific formula and is useful in the treatment and prevention of various disorders. The patent outlines a method for screening lipase inhibitors using this compound, which includes in vitro assays and cellular assays to determine its lipase inhibitory activity. Furthermore, the patent describes methods for treating or preventing conditions involving cachexia, stroke, atherosclerosis, coronary artery disease, and diabetes, particularly type II diabetes, by administering a pharmaceutical composition that inhibits ATGL.
Career Highlights
Throughout his career, Matthias Romauch has been associated with prestigious institutions such as Technische Universität Graz and Karl-Franzens-Universität Graz. His academic and research endeavors have significantly contributed to advancements in pharmaceutical sciences.
Collaborations
Romauch has collaborated with notable colleagues, including Martina Schweiger and Robert Zimmermann. These partnerships have fostered a collaborative environment that enhances research and innovation in the pharmaceutical field.
Conclusion
Matthias Romauch is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the treatment of various serious health conditions. His innovative approaches and collaborations continue to drive advancements in the field.